Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes Adds Multi-Disciplinary Team and Capabilities Harnessing the Power of Next-Generation Sequencing (NGS), Population Scale Clinical Studies, and Machine Learning to Address One of Medicine’s Greatest Challenges Brings Significant New Growth Opportunities in the Clinical Setting [...]

KromaTiD Announces the Appointment of Vic Myer, PhD to its Board of Directors

LONGMONT, Colo. -- KromaTiD, Inc. today announced the appointment of Vic Myer to its Board of Directors. Dr. Myer joins KromaTiD's Board with extensive experience in technology, R&D and pharmaceutical company executive leadership, including 5 years of experience as Chief Technology Officer of Editas Medicine, a leading developer of gene editing-based therapies. He is currently Entrepreneur in Residence [...]

PerkinElmer Launches Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples

Solution Receives AOAC® PTM SM Certification WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay. This new offering will help high throughput food processors and contract labs focus on L. mono testing for food and environmental surface samples. In sync with leading industry [...]

Upgrade of RiboCop rRNA Depletion Kit and Launch of Combined rRNA & Globin Depletion Kit

Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for ~35-80 % of mRNA in blood samples. Therefore, RNA sample preparation for sequencings requires stringent rRNA and (for blood samples) globin depletion. The upgraded version [...]

MP Biomedicals facility in India is awarded both ISO 9001:2015 and WHO GMP certification

MP Biomedicals proudly announces the recent award of ISO 9001:2015 and WHO GMP certifications for manufacturing facility located in Navi Mumbai, in Maharashtra state of India. The manufacturing facility accounts for production of cell culture media, buffers, solutions, sterile water for injection, and many more. This moves MP Biomedicals to support the global demands and requirements of [...]

BIO-TECHNE AND QIAGEN ANNOUNCE EXPANSION AND EXTENSION OF EXOSOME PARTNERSHIP

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products. The agreement grants QIAGEN a non-exclusive development license to Bio-Techne's exosome technology for the development [...]

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

• Transaction strengthens QIAGEN’s leadership position in automated molecular testing • QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million • Medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology to now be integrated into QIAGEN’s portfolio on a global basis • Menu of test solutions for infectious diseases – [...]

Cardea Bio Announces $7.5M in First Close of Series A2 Financing

Financing to support commercial launch of multiple “Powered by Cardea” product collaborations under the Cardea Innovation Partnership Program and accelerated growth of the Tech+Bio Infrastructure. SAN DIEGO -- Cardea Bio Inc., who is integrating tiny bits of biology into modern electronics, via their Graphene-based Biology-gated Transistors (“Cardean Transistors™”), just announced the first closing in their [...]

Octapharma Chooses Genedata Selector for NGS-Based Cell Line Development

Leading manufacturer of therapeutic proteins to invest in enterprise software to digitalize innovation in NGS-based cell line development Basel, Switzerland  – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of the world’s leading manufacturers of therapeutic human proteins, has chosen Genedata Selector® as its central computational platform [...]

Optimized Medium for Expansion of Mesenchymal Stem Cells

AMSBIO announce StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells. StemFit® for Mesenchymal Stem Cells (MSC) is the latest addition to the StemFit® family of stem cell media. It is a chemically defined and human/animal origin free medium, optimized for the isolation and culture of MSCs [...]

Access IBO on Knowledge Center